OMX Copenhagen 20
1.640,85
PKT
+2,73
PKT
+0,17
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
Datum | Rating | Analyst | |
---|---|---|---|
06.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
02.01.25 | A.P. Moeller - Maersk A-S (B) Underperform | Bernstein Research | |
23.12.24 | Novo Nordisk Overweight | Barclays Capital | |
23.12.24 | Novo Nordisk Halten | DZ BANK | |
20.12.24 | Novo Nordisk Underperform | Bernstein Research | |
20.12.24 | Novo Nordisk Neutral | UBS AG | |
20.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
17.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
16.12.24 | Novo Nordisk Neutral | UBS AG | |
16.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
12.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
10.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
09.12.24 | Novo Nordisk Neutral | UBS AG | |
09.12.24 | Novo Nordisk Underperform | Bernstein Research | |
04.12.24 | Novo Nordisk Underperform | Bernstein Research | |
04.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
04.12.24 | A.P. Moeller - Maersk A-S (B) Underweight | JP Morgan Chase & Co. | |
03.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
02.12.24 | Novo Nordisk Neutral | UBS AG | |
01.12.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
27.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
27.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
18.11.24 | Novo Nordisk Neutral | UBS AG | |
15.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
14.11.24 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
13.11.24 | Novo Nordisk Neutral | UBS AG | |
11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
11.11.24 | Novo Nordisk Neutral | UBS AG | |
11.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
08.11.24 | Novo Nordisk Overweight | Barclays Capital | |
07.11.24 | Novo Nordisk Neutral | UBS AG | |
07.11.24 | Novo Nordisk Halten | DZ BANK | |
07.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
07.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.11.24 | Novo Nordisk Neutral | UBS AG | |
06.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
06.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.11.24 | Novo Nordisk Neutral | UBS AG | |
06.11.24 | Novo Nordisk Underperform | Jefferies & Company Inc. |